This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: The Hong Kong Polytechnic University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Albert Sun Chi Chan: Innovator in Anti-Cancer Research
Introduction
Albert Sun Chi Chan is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of anti-cancer research, particularly through his innovative work on quinoline derivatives. His research focuses on developing compounds that exhibit anticancer activities against various cancer cell lines.
Latest Patents
Albert Sun Chi Chan holds a patent for "Quinoline derivatives as anti-cancer agents." This patent highlights the effectiveness of quinoline derivatives against cancer cell lines, including hepatocellular carcinoma (Hep3B), lung carcinoma (A549), and esophageal squamous cell carcinoma (HKESC-1, HKESC-4, and KYSE150). The quinoline derivatives feature a unique backbone structure that enhances their anticancer properties. He has 1 patent to his name.
Career Highlights
Albert is affiliated with The Hong Kong Polytechnic University, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential impact on cancer treatment and therapy.
Collaborations
Some of his notable coworkers include Johnny Cheuk-on Tang and Kim Hung Lam. Their collaborative efforts have further advanced the research in the field of anti-cancer agents.
Conclusion
Albert Sun Chi Chan is a dedicated inventor whose work in developing quinoline derivatives as anti-cancer agents showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile